Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes

The production of cytotoxic T cells with specificity for cancer cells is a rapidly evolving branch of cancer therapeutics. A variety of approaches aim to amplify anti-tumour cytotoxic T cell responses using purified peptides, tumour cell lysates or recombinant HLA/peptide complexes in differing anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Savage, P, Cowburn, P, Clayton, A, Man, S, McMichael, A, Lemoine, N, Epenetos, A, Ogg, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375334/
https://www.ncbi.nlm.nih.gov/pubmed/11953895
http://dx.doi.org/10.1038/sj.bjc.6600223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375334/
https://www.ncbi.nlm.nih.gov/pubmed/11953895
http://dx.doi.org/10.1038/sj.bjc.6600223

Ejemplares similares